Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Authors’ reply to Dr. Golan

  • Ruth Ann Marrie, Neurologist, University of Manitoba
  • Christiane Whitehouse, Graduate student, Dalhousie University
  • John Fisk, Neuropsychologist, Dalhousie University
Submitted February 21, 2019

We thank Dr. Golan for the comment on our article.1 We agree that immune-mediated inflammatory disease (IMID) activity and severity are associated with anxiety but disagree with the conclusion drawn. In longitudinal studies, we have shown that psychiatric comorbidity is associated with greater multiple sclerosis–related disability progression over time.2 Similarly, in inflammatory bowel disease (IBD), elevated symptoms of anxiety at baseline are associated with a shorter time to recurrence of clinical IBD symptoms.3 Therefore, IMID severity or disease activity would fall in the causal pathway between anxiety and cognition, and should not be treated as confounders, because this would create overadjustment bias.4 In the general population, anxiety is known to adversely affect cognition. This is consistent with findings among our study participants who had depression or anxiety, but who did not have an IMID. Moreover, the strength of the association between anxiety and cognition was the same across all groups. Collectively, these observations indicate that the reported association between anxiety and cognition is not solely explained by unmeasured confounding.

References

  1. Whitehouse C, Fisk J, Bernstein C, et al. Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders. Neurology 2019;92:e406–e417.
  2. McKay KA, Tremlett H, Fisk JD, et al. Psychiatric Comorbidity Is Associated with Disability Progression in Multiple Sclerosis. Neurology 2018;90:e1316–e1323.
  3. Mikocka-Walus A, Pittet V, Rossel JB, von Kanel R. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clin Gastroenterol Hepatol 2016;14:829–835.
  4. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009;20:488–495.

Footnote

For disclosures, please contact the editorial office at journal@neurology.org.

Navigate back to article

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise